There is intense interest among scholars and the public in questions related to the risks, benefits, and pricing of pharmaceuticals--but relatively little attention has been devoted to vaccine markets and the political, economic, and regulatory factors that influence their development. This important new study investigates the key business drivers and challenges of vaccine markets, the complex interactions among their important stakeholders, and the emerging opportunities for growth.